Health Outcomes Among Patients Diagnosed with Schizophrenia in the US Veterans Health Administration Population Who Transitioned from Once-Monthly to Once-Every-3-Month Paliperidone Palmitate: An Observational Retrospective Analysis

导出原文传递

翻译打印收藏纠错

作者： Patel, Charmi ^[1] ; El Khoury, Antoine ^[2] ; Huang, Ahong ^[3] ; Wang, Li ; Baser, Onur ; Joshi, Kruti

作者单位： STATinMED, 5340 Legacy Dr,Suite 175, Plano, TX 75024 USA ^[1] MEF Univ, Dept Econ, Leylak Sk 22, TR-34340 Istanbul, Turkey ^[2] Janssen Sci Affairs LLC, 920 Rte 202, Raritan, NJ 08869 USA ^[3]

关键词 Antipsychotic agents Healthcare costs Schizophrenia Medication adherence Neurology Paliperidone palmitate

发布时间 2020-03-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Advances in therapy.

2019年36卷10期

2941-2953页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Health Outcomes Among Patients Diagnosed with Schizophrenia in the US Veterans Health Administration Population Who Transitioned from Once-Monthly to Once-Every-3-Month Paliperidone Palmitate: An Observational Retrospective Analysis

Advances in therapy.

相似文献

Advances in therapy.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Health Outcomes Among Patients Diagnosed with Schizophrenia in the US Veterans Health Administration Population Who Transitioned from Once-Monthly to Once-Every-3-Month Paliperidone Palmitate: An Observational Retrospective Analysis

Advances in therapy.

相似文献

Advances in therapy.

相关期刊

检索历史清除